Lv5
960 积分 2026-01-06 加入
In vivo evaluation of Clostridioides difficile enoyl-ACP reductase II (FabK) inhibition by phenylimidazole unveils a promising narrow-spectrum antimicrobial strategy
17天前
已完结
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesity
4个月前
已完结
794-P: MET-097: Preclinical Characterization of a Potent and Ultra-Long-Acting GLP-1 Receptor Agonist
4个月前
已关闭
P0033 Repositioning dual GLP-1/GIP receptor agonists for the treatment of colitis and colitis-associated cancer (CAC)
5个月前
已完结
Peptide Hormones and Bile Acids Shaping Immune Tolerance of the Liver: Implications and Applications
5个月前
已完结
Glucagon-Like Peptide-1 (GLP-1) receptor agonists in rheumatology: A review of current evidence and future directions
5个月前
已完结
REPOSITIONING DUAL GLP-1/GIP RECEPTOR AGONISTS FOR THE TREATMENT OF COLITIS AND COLITIS-ASSOCIATED TUMORIGENESIS
5个月前
已完结
Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide delivery
5个月前
已关闭
Peptide Hormones and Bile Acids Shaping Immune Tolerance of the Liver: Implications and Applications
5个月前
已完结